EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Relationship between the concentration of ergothioneine in plasma and the likelihood of developing pre-eclampsia

Louise C Kenny, SCOPE Consortium, Leslie W Brown, Paloma Ortea, Robin Tuytten, Douglas B Kell iD

Bioscience Reports · 26.07.2023 · 43 (7)

DOI: 10.1042/bsr20230160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioscience Reports, online erschienen am 06.07.2023. Verfasst von Louise C Kenny und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women's and Children's Health, Faculty of Health and Life Sciences, University of Liverpool, Liverpool L7 8TX, U.K. Hauptthemen laut MEDLINE: Pre-Eclampsia, Ergothioneine. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU, NNF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ergothioneine, an antioxidant nutraceutical mainly at present derived from the dietary intake of mushrooms, has been suggested as a preventive for pre-eclampsia (PE). We analysed early pregnancy samples from a cohort of 432 first time mothers as part of the Screening for Endpoints in Pregnancy (SCOPE, European branch) project to determine the concentration of ergothioneine in their plasma. There was a weak association between the ergothioneine levels and maternal age but none for BMI. Of these 432 women, 97 went on to develop pre-term (23) or term (74) PE. If a threshold was set at the 90th percentile of the reference range in the control population (≥462 ng/ml), only one of these 97 women (1%) developed PE, versus 96/397 (24.2%) whose ergothioneine level was below this threshold. One possible interpretation of these findings, consistent with previous experiments in a reduced uterine perfusion model in rats, is that ergothioneine may indeed prove protective against PE in humans. An intervention study of some kind now seems warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaErgothioneinePregnancyFemaleRatsHumansAnimalsAntioxidantsDietary SupplementsUterusBiomarkers

Stichwörter der Autor:innen

ErgothioneineMetabolomicsOxidative stressPreeclampsia

Substanzen

ErgothioneineAntioxidantsBiomarkers

Autor:innen und Institutionen

  • Department of Women's and Children's Health, Faculty of Health and Life Sciences, University of Liverpool, Liverpool L7 8TX, U.K.
  • Metabolomic Diagnostics, Cork, Ireland.
  • Department of Biochemistry and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Crown St, Liverpool L69 7BX, U.K.
  • Novo Nordisk Foundation Centre for Biosustainability, Technical University of Denmark, Kemitorvet 200, 2800 Kgs Lyngby, Denmark.

ORCID-Profile: Douglas B Kell

Förderung

  • EU
  • NNF

Zitieren

APA

Kenny, L. C., SCOPE Consortium, Brown, L. W., Ortea, P., Tuytten, R., & Kell, D. B. (2023). Relationship between the concentration of ergothioneine in plasma and the likelihood of developing pre-eclampsia. Bioscience Reports, 43(7). https://doi.org/10.1042/bsr20230160

Vancouver

Kenny LC, SCOPE Consortium, Brown LW, Ortea P, Tuytten R, Kell DB. Relationship between the concentration of ergothioneine in plasma and the likelihood of developing pre-eclampsia. Bioscience Reports. 2023;43(7). doi:10.1042/bsr20230160

BibTeX
@article{Kenny2023,
  author = {Kenny, Louise C and SCOPE Consortium, SCOPE Consortium and Brown, Leslie W and Ortea, Paloma and Tuytten, Robin and Kell, Douglas B},
  title = {Relationship between the concentration of ergothioneine in plasma and the likelihood of developing pre-eclampsia},
  journal = {Bioscience Reports},
  year = {2023},
  volume = {43},
  number = {7},
  doi = {10.1042/bsr20230160}
}
Kostenlos starten →